Intellectual Property Magazine
Pozen victory against generics
United States
Sophie Roberts - Staff Reporter
A Texas court has sided with pharmaceutical company Pozen against several generic pharmaceutical companies which filed Abbreviated
New Drug Applications (ANDAs) seeking approval from the US Food and Drug Administration (FDA) to market generic copies of
Pozen's migraine drug.